(19)
(11) EP 2 986 631 A1

(12)

(43) Date of publication:
24.02.2016 Bulletin 2016/08

(21) Application number: 14718403.0

(22) Date of filing: 16.04.2014
(51) International Patent Classification (IPC): 
C07K 14/47(2006.01)
A61K 38/00(2006.01)
(86) International application number:
PCT/EP2014/057830
(87) International publication number:
WO 2014/170411 (23.10.2014 Gazette 2014/43)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 16.04.2013 GB 201306886
14.08.2013 GB 201314544

(71) Applicant: Orbsen Therapeutics Limited
Galway (IE)

(72) Inventor:
  • ELLIMAN, Stephen Joseph
    Galway (IE)

(74) Representative: Schlich, George et al
Schlich 9 St Catherine's Road
Littlehampton, West Sussex BN17 5HS
Littlehampton, West Sussex BN17 5HS (GB)

   


(54) MEDICAL USE OF SYNDECAN-2